Clinical trial
Efficacy and Safety of NNC-0156-0000-0009 During Surgical Procedures in Subjects…
NCT01386528 · Novo Nordisk A/S, Industry · Completed
Key facts
| NCT number | NCT01386528 |
|---|---|
| Title | Efficacy and Safety of NNC-0156-0000-0009 During Surgical Procedures in Subjects With Haemophilia B |
| Official title | An Open-label, Multi-centre, Un-controlled Trial to Assess Efficacy and Safety of NNC-0156-0000-0009 During Surgical Procedures in Patients With Haemophilia B |
| Acronym | paradigm™ 3 |
| Lead sponsor | Novo Nordisk A/S, Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Congenital Bleeding Disorder, Haemophilia B |
| Intervention type | Drug |
| Interventions | nonacog beta pegol |
| Enrollment | 13 |
| Start date | Jun 7, 2012 |
| Primary completion | Dec 1, 2013 |
| Completion | Dec 1, 2013 |
| First posted | Jul 1, 2011 |
| Last update posted | Aug 23, 2017 |
| Countries | Austria, France, Germany, Greece, Italy, Japan, Malaysia, Netherlands, North Macedonia, Romania, South Africa, Spain and 5 more |
At a glance
- 10–99 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: